PAHC

NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Dollar change +0.31
Percentage change 1.27	%

Peers: ZTS ELAN IDXX NEOG MWG CTLT KMDA MNOV IRWD PTCT

| Held by: IJR VTI IWM VXF AVUV IJT SPSM IWN DES DWAS

Scroll to Statements

Index	RUT	P/E	31.70	EPS (ttm)	0.78	Insider Own	50.12%	Shs Outstand	20.37M	Perf Week	0.24%
Market Cap	1.00B	Forward P/E	11.02	EPS next Y	2.25	Insider Trans	0.02%	Shs Float	20.22M	Perf Month	7.60%
Enterprise Value	1.70B	PEG	1.10	EPS next Q	0.52	Inst Own	50.28%	Short Float	4.49%	Perf Quarter	12.28%
Income	31.79M	P/S	0.84	EPS this Y	70.78%	Inst Trans	-2.16%	Short Ratio	3.86	Perf Half Y	16.46%
Sales	1.19B	P/B	3.77	EPS next Y	10.65%	ROA	2.77%	Short Interest	0.91M	Perf YTD	17.95%
Book/sh	6.56	P/C	14.27	EPS next 5Y	28.71%	ROE	11.86%	52W High	26.55 -6.70%	Perf Year	39.63%
Cash/sh	1.74	P/FCF	20.47	EPS past 3/5Y	-64.59% -46.42%	ROIC	3.15%	52W Low	16.16 53.28%	Perf 3Y	38.46%
Dividend Est.	0.48 (1.94%)	EV/EBITDA	10.34	Sales past 3/5Y	6.89% 4.21%	Gross Margin	32.51%	Volatility	1.90% 1.76%	Perf 5Y	-4.33%
Dividend TTM	0.48 (1.94%)	EV/Sales	1.43	EPS Y/Y TTM	141.45%	Oper. Margin	10.27%	ATR (14)	0.79	Perf 10Y	-25.77%
Dividend Ex-Date	Jun 04, 2025	Quick Ratio	1.23	Sales Y/Y TTM	19.12%	Profit Margin	2.67%	RSI (14)	60.81	Recom	3.25
Dividend Gr. 3/5Y	0.00% 0.85%	Current Ratio	2.91	EPS Q/Q	147.30%	SMA20	1.83%	Beta	0.74	Target Price	22.25
Payout	805.37%	Debt/Eq	2.89	Sales Q/Q	32.14%	SMA50	13.17%	Rel Volume	0.61	Prev Close	24.46
Employees	1940	LT Debt/Eq	2.80	Earnings	May 07 AMC	SMA200	11.07%	Avg Volume	235.22K	Price	24.77
IPO	Apr 11, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	21.04% -1.25%	Trades		Volume	143,219	Change	1.27%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-16-25	Upgrade	BNP Paribas Exane	Underperform → Neutral	$24
Sep-10-24	Initiated	JP Morgan	Neutral	$22
Dec-07-23	Initiated	Exane BNP Paribas	Underperform	$9
Dec-21-22	Initiated	ROTH Capital	Buy	$18
Jul-25-22	Downgrade	Barclays	Equal Weight → Underweight	$22
Jan-10-22	Upgrade	Barclays	Underweight → Equal Weight	$23
Nov-18-21	Initiated	Morgan Stanley	Equal-Weight	$23
Aug-05-21	Resumed	Credit Suisse	Neutral	$25
Jul-07-21	Downgrade	Barclays	Equal Weight → Underweight	$23
Aug-06-20	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$20
Feb-06-20	Downgrade	Gabelli & Co	Buy → Hold	$30
Jan-28-20	Upgrade	Barclays	Underweight → Equal Weight
Sep-05-19	Upgrade	Morgan Stanley	Underweight → Equal-Weight	$21 → $30
Aug-29-19	Reiterated	BofA/Merrill	Underperform	$29 → $18
Jun-11-19	Initiated	Barclays	Underweight	$25
May-23-19	Initiated	Guggenheim	Neutral
May-09-19	Upgrade	Gabelli & Co	Hold → Buy	$42
Aug-23-17	Resumed	BofA/Merrill	Underperform	$33
Jun-02-17	Downgrade	Credit Suisse	Outperform → Neutral
Dec-15-16	Initiated	Piper Jaffray	Overweight

Show Previous Ratings

Today 09:33AM	Should You Continue to Retain Abbott Stock in Your Portfolio Now? (Zacks)
Jun-23-25 12:45PM	Is Phibro (PAHC) a Solid Growth Stock? 3 Reasons to Think "Yes" (Zacks)
Jun-20-25 11:30AM	Why Is Medtronic (MDT) Up 6% Since Last Earnings Report? (Zacks)
Jun-19-25 08:35AM	QIAGEN's New QIAcuity dPCR IVD Pact With GENCURIX May Boost Its Stock (Zacks)
Jun-18-25 09:22AM	Reasons to Add PAHC Stock to Your Portfolio Right Now (Zacks)
08:28AM	Loading…
08:28AM	Labcorp Stock Climbs 25.6% This Year: What's Driving the Surge? (Zacks)
Jun-17-25 09:40AM	Why This 1 Value Stock Could Be a Great Addition to Your Portfolio (Zacks)
08:39AM	DGX Stock Up on New Blood Test Development Deal With MD Anderson (Zacks)
Jun-16-25 08:27AM	QGEN Stock Rises in After Market Following Partnership With Incyte (Zacks)
08:25AM	Should You Hold Myriad Genetics Stock in Your Portfolio Right Now? (Zacks)
07:26AM	Zacks.com featured highlights include Popular, Affiliated Managers, Astronics and Phibro Animal Health (Zacks)
Jun-13-25 12:13PM	Should You Add QIAGEN Stock to Your Portfolio for Now? (Zacks)
11:40AM	PAHC vs. BSX: Which Stock Should Value Investors Buy Now? (Zacks)
11:34AM	4 Stocks Trading Near 52-Week High With More Upside Potential (Zacks)
11:21AM	Thermo Fisher Stock Hurt by Macroeconomic Woes, Tough Competition (Zacks)
09:40AM	Loading…
09:40AM	Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now? (Zacks)
08:27AM	Here's Why You Should Retain AMED Stock in Your Portfolio for Now (Zacks)
Jun-12-25 09:15AM	Brainsway Ltd. Sponsored ADR (BWAY) Hits Fresh High: Is There Still Room to Run? (Zacks)
Jun-11-25 09:51AM	Here's Why You Should Retain PODD Stock in Your Portfolio Now (Zacks)
08:35AM	Should You Continue to Hold Prestige Consumer Stock in Your Portfolio? (Zacks)
Jun-10-25 08:06AM	Bruker Stock Set to Gain From Acquisition of Austria's biocrates (Zacks)
Jun-09-25 08:37AM	PEN Stock Rises Following the Launch of Ruby XL System (Zacks)
Jun-06-25 11:31AM	Phibro (PAHC) Up 7.4% Since Last Earnings Report: Can It Continue? (Zacks)
09:50AM	Why Phibro Animal Health (PAHC) is a Top Momentum Stock for the Long-Term (Zacks)
09:02AM	Is it Apt to Retain Omnicell Stock in Your Portfolio Now? (Zacks)
Jun-05-25 08:52AM	Should You Continue to Hold EXAS Sciences Stock in Your Portfolio? (Zacks)
Jun-04-25 08:34AM	Should You Continue to Hold Labcorp Stock in Your Portfolio? (Zacks)
05:26AM	Zacks.com featured highlights Urban Outfitters, Phibro Animal Health and Strattec Security (Zacks)
Jun-03-25 03:00PM	3 Stocks Showing Positive Momentum Despite Trade Tensions (Zacks)
10:09AM	TMO Launches Next-Generation Mass Spectrometers: Stock to Gain? (Zacks)
08:08AM	Loading…
08:08AM	QGEN Stock to Gain From Expanding Oncology Portfolio via New Alliances (Zacks)
Jun-02-25 10:23AM	Here's Why You Should Retain ICLR Stock in Your Portfolio Now (Zacks)
10:18AM	LH Stock Rises Following the Expansion of Precision Oncology Portfolio (Zacks)
08:12AM	Charles River Stock May Gain From Extended CHDI Research Deal on HD (Zacks)
May-30-25 10:09AM	Abbott Benefits From Libre & Biosimilars Amid FX, Cost Headwinds (Zacks)
09:27AM	Illumina Introduces a New AI algorithm PromoterAI: Stock to Gain? (Zacks)
08:16AM	Thermo Fisher Launches New Spectral Flow Cytometer: Stock to Gain? (Zacks)
May-29-25 09:40AM	Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock (Zacks)
09:31AM	Alcon Stock Rises Following the FDA Approval of TRYPTYR (Zacks)
08:54AM	Bruker Stock to Gain From the Launch of MOVE-T Liquid Dairy Analyzer (Zacks)
08:47AM	Is Bio-Techne Stock the Right Pick for Your Portfolio Now? (Zacks)
May-28-25 12:45PM	Phibro (PAHC) is an Incredible Growth Stock: 3 Reasons Why (Zacks)
11:40AM	PAHC or BSX: Which Is the Better Value Stock Right Now? (Zacks)
09:40AM	Is Phibro Animal Health (PAHC) Stock Undervalued Right Now? (Zacks)
09:22AM	Abbott Stock Gains Following FDA Approval of the Tendyne System (Zacks)
08:12AM	Illumina's TSO Comprehensive Earns Japan's Approval: Stock to Gain? (Zacks)
May-27-25 08:15AM	Prestige Consumer Gains 35.7% in a Year: What's Driving the Stock? (Zacks) +5.25%
May-26-25 08:38AM	TMO Stock Set to Gain From the Launch of New Narcotic Analyzers (Zacks)
08:30AM	Should You Retain Henry Schein Stock in Your Portfolio Right Now? (Zacks)
08:30AM	Insulet Gains 78.5% in a Year: What's Driving the Stock? (Zacks)
May-23-25 09:52AM	4 Stocks Trading Near 52-Week High With Room to Rise Further (Zacks)
08:53AM	Edwards' New Late-Breaking Data on Severe AS Expected to Boost Stock (Zacks)
04:50AM	Best Growth Stocks to Buy for May 23rd (Zacks)
04:37AM	Best Value Stocks to Buy for May 23rd (Zacks)
03:42AM	Best Income Stocks to Buy for May 23rd (Zacks)
May-22-25 04:00PM	Phibro Animal Health Corporation to Participate at Stifel Jaws & Paws Conference (Business Wire)
06:46AM	Penumbra Rallies 35.9% in a Year: What's Driving the Stock? (Zacks)
06:38AM	Should Tandem Diabetes Stock Stay in Your Portfolio Now? (Zacks)
May-21-25 12:00PM	What Makes Phibro Animal Health (PAHC) a Strong Momentum Stock: Buy Now? (Zacks)
11:36AM	AST Business Growth & Strategic Acquisitions Support STERIS Stock (Zacks)
09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
09:10AM	Medtronic Q4 Earnings and Revenues Top, Stock Down in Pre-market (Zacks)
07:49AM	What's Driving Quest Diagnostics Stock's 25.6% Rally in a Year? (Zacks)
May-20-25 08:53AM	Should You Continue to Hold Charles River Stock in Your Portfolio? (Zacks)
08:49AM	Illumina Stock to Gain From the Launch of New DRAGEN v4.4 Software (Zacks)
May-19-25 08:38AM	Veracyte Stock Surges 30.9% in a Year: What's Driving the Rally? (Zacks)
May-16-25 07:47AM	Should You Continue to Hold Medtronic Stock in Your Portfolio Now? (Zacks)
06:34AM	Should Edwards Lifesciences Stock Remain in Your Portfolio Now? (Zacks)
May-15-25 08:40AM	STE Q4 Earnings Beat, Margins Expand, Stock Up in Aftermarket (Zacks)
May-14-25 07:11AM	Is it Worth Retaining Boston Scientific Stock in Your Portfolio Now? (Zacks) -5.04%
May-13-25 09:40AM	Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term (Zacks)
09:16AM	International Markets and Phibro (PAHC): A Deep Dive for Investors (Zacks)
07:48AM	Should You Continue to Retain DGX Stock in Your Portfolio? (Zacks)
May-12-25 12:45PM	3 Reasons Growth Investors Will Love Phibro (PAHC) (Zacks) +9.03%
11:40AM	PAHC or BSX: Which Is the Better Value Stock Right Now? (Zacks)
09:40AM	Should Value Investors Buy Phibro Animal Health (PAHC) Stock? (Zacks)
May-09-25 03:25AM	Phibro Animal Health Corp (PAHC) Q3 2025 Earnings Call Highlights: Robust Sales Growth and ... (GuruFocus.com)
May-08-25 08:13AM	Phibro Q3 Earnings Top Estimates, Stock Up, 2025 EPS Outlook Raised (Zacks) +14.75%
May-07-25 08:30PM	Compared to Estimates, Phibro (PAHC) Q3 Earnings: A Look at Key Metrics (Zacks)
07:40PM	Phibro Animal Health (PAHC) Q3 Earnings Beat Estimates (Zacks)
06:33PM	Phibro: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:30PM	Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance (Business Wire)
May-06-25 04:15PM	Phibro Animal Health Corporation Declares Quarterly Dividend (Business Wire)
May-01-25 10:01AM	Haemonetics (HAE) Earnings Expected to Grow: Should You Buy? (Zacks)
Apr-30-25 10:01AM	Phibro Animal Health (PAHC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Apr-24-25 09:40AM	Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock (Zacks)
Apr-23-25 04:00PM	Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Results (Business Wire)
Apr-22-25 11:25AM	Phibro Animal Health price target lowered to $18 from $22 at BofA (TipRanks)
Apr-16-25 11:40AM	PAHC or BSX: Which Is the Better Value Stock Right Now? (Zacks)
09:40AM	Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now? (Zacks)
09:35AM	Here's Why Phibro (PAHC) is Poised for a Turnaround After Losing -22.25% in 4 Weeks (Zacks)
Apr-11-25 09:35AM	Here's Why Phibro (PAHC) is Poised for a Turnaround After Losing -13.52% in 4 Weeks (Zacks)
Apr-10-25 11:36AM	InMode (INMD) Soars 6.8%: Is Further Upside Left in the Stock? (Zacks) -7.03%
Apr-09-25 12:45PM	Here is Why Growth Investors Should Buy Phibro (PAHC) Now (Zacks) +6.60%
08:57AM	Top 3 MedTech Stocks to Weather the Trump Tariff Turbulence (Zacks)
08:39AM	Is it the Right Time to Add EYE Stock to Your Portfolio Now? (Zacks)
Apr-08-25 09:57AM	Reasons to Retain Penumbra Stock in Your Portfolio for Now (Zacks)
09:40AM	Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term (Zacks)
Apr-04-25 08:09AM	Reasons to Add ABT Stock to Your Portfolio Right Now (Zacks) -5.09%
Apr-02-25 07:27AM	Is it Worth Retaining Thermo Fisher Stock in Your Portfolio Now? (Zacks)

Phibro Animal Health Corp. engages in the development, manufacture, and marketing of animal health and mineral nutrition products. It operates through the following segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops and markets medicated feed additives, nutritional specialty products, and vaccines. The Mineral Nutrition segment includes formulations and concentrations of trace minerals such as zinc, manganese, copper, iron, and compounds. The Performance Products segment produces specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries. The company was founded on May 11, 1946 and is headquartered in Teaneck, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BFI Co., LLC	10% Owner	May 19 '25	Proposed Sale	24.00	241,129	5,787,096		May 19 05:25 PM
CORCORAN E THOMAS	Director	Feb 24 '25	Buy	22.10	5,000	110,500	30,000	Feb 26 04:15 PM
BFI Co., LLC	10% Owner	Feb 18 '25	Proposed Sale	25.77	247,769	6,385,007		Feb 18 05:35 PM
CORCORAN E THOMAS	Director	Sep 04 '24	Buy	20.02	5,000	100,100	25,000	Sep 06 04:34 PM
BFI Co., LLC	10% Owner	Aug 13 '24	Proposed Sale	17.29	257,400	4,450,446		Aug 13 05:20 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Phibro Animal Health Corp

Upgrade your FINVIZ experience